$AIMD

lee ting-chuan sold $14K of AIMD

lee ting-chuan sold 9,000 shares of Ainos, Inc. (AIMD) at $1.56 on 2026-05-21.

Original reporting
SEC EDGAR · lee ting-chuan
Published May 26, 2026, 8:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 26, 2026, 8:19 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AIMD
Bearish
medium confidence
Mentioned
$AIMD
Relevance
8/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIMDBearishMed
01

Why it matters

Traders may reassess near-term sentiment, but the disclosure lacks accompanying operational or financial updates.

02

Market read

Insider selling disclosure can affect micro-sentiment, though the dollar value is modest and no 10b5-1 plan is cited.

03

What to watch

Single-trade size ($14.0k) is small relative to typical market caps; without follow-on insider buys/sales or operational news, signal-to-noise is low.

Relevance 8/10Timing: Immediate (filed 2026-05-26; trade dated 2026-05-21) for short-term sentiment/positioning.

Background

The article is an SEC Form 4 insider transaction disclosure for Ainos, Inc. (AIMD).

Company-level read

Ticker impact

$AIMDBearishMedium confidence
Context

Ainos director lee ting-chuan sold 9,000 shares in an open-market transaction ($1.56/share) disclosed via SEC Form 4.

Expected impact

Likely modest downward pressure or increased volatility around the filing; no strong directional move expected solely from this trade.

Evidence & confidence

This is a single director sale (direct holdings reduced to 926,707) with no 10b5-1 plan stated; insider sales often have mixed interpretation absent broader company catalysts.

Market effects

Minimal—this is company-specific insider activity with no sector-wide catalyst mentioned.

None indicated; filing is US SEC EDGAR with no geographic demand/supply shock.

None indicated; no international deal/regulatory development referenced.

Counterpoint

The sale could be routine liquidity/portfolio rebalancing; the absence of a stated 10b5-1 plan doesn’t necessarily imply negative fundamentals.

Key entities

  • Ainos, Inc.

    Subject of the insider transaction disclosure; director sold shares open-market.

  • lee ting-chuan

    Director who sold 9,000 shares at $1.56/share on 2026-05-21.

Related articles

$AIMDLow

Ainos, Inc. (AIMD): Results of Operations and Financial Condition

Ainos, Inc. (AIMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Ainos Reports Second Quarter 2026 Results and Highlights Continued AI Nose Execution Across Industrial, Healthcare Infrastructure and Robotics Markets Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) (“Ainos” or the “Company”) today announced resu

$AIMDMed

Ainos, Inc.: VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations

Ainos, Inc. (NASDAQ:AIMD) said VASRO GmbH highlighted its AI Nose platform’s expansion into live emergency department operations. VASRO reports a research program at an Asia academic medical center to generate 2,500+ hours of emergency-department environmental scent data for overcrowding early warning and respiratory infection risk analysis. The initiative broadens evaluations beyond industrial settings and supports Ainos’ Smell Language Model development.